theMednetRegister
  • Community
    • Overview
    • Experts
    • Editors
    • Fellows
    • Code of conduct
    • AI Guidelines for Physicians
  • Company
    • About Us
    • FAQs
    • Privacy Policy
    • Terms of Use
    • Careers
    • Programs
  • News
    • News Releases
    • Press Coverage
    • Publications
    • Blog
  • Contact Us
  • Sign in

Infectious Disease

NCI-CCC Tumor Board Question   

These are questions being discussed by academics at NCI-Cancer Centers

Questions discussed in this category


What infectious prophylaxis do you use for patients with newly diagnosed multiple myeloma?
How do you decide how long to continue?
1 Answer available
11799


Papers discussed in this category


Lancet Oncol, 2019 Oct 23
Levofloxacin prophylaxis in patients with newly diagnosed myeloma (TEAMM): a multicentre, double-blind, placebo-controlled, randomised, phase 3 trial.

Related Topics in Infectious Disease

  • Breast Cancer
  • Hematologic Malignancies
  • Radiation Oncology
  • Gynecologic Oncology
  • Gastrointestinal Cancers
  • Pediatric Hematology/Oncology
  • Sarcoma
  • Thoracic Malignancies
  • Bladder Cancer
  • Medical Oncology

Copyright © 2025 theMednet
All Rights Reserved.